Navigation Links
Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
Date:2/12/2008

324 267

Long-term debt, net of current portion - 1,262

Commitments and contingencies

Stockholders' equity :

Preferred stock - 52

Common stock 16 -

Additional paid-in capital 132,532 59,362

Accumulated other comprehensive income 53 -

Accumulated deficit (41,996) (55,349)

Total stockholders' equity 90,605 4,065

Total liabilities and stockholders' equity $97,832 $10,202

GENOPTIX, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

Three Months Ended Years Ended

December 31, December 31,

2007 2006 2007 2006

(unaudited)(unaudited)

Revenues $18,562 $7,828 $59,332 $24,018

Cost of revenues 7,563 3,823 24,106 13,131

Gross profit 10,999 4,005 35,226 10,887

Operating expenses:

Sales and marketing expenses 3,780 2,127 11,649 6,264

General and administrative expenses 2,979 1,962 9,976 6,930

Research and development expenses 96 220 559 1,080

Impairment and lease exit costs - - - 542

Total operating expenses 6,855 4,309 22,184 14,816

Income (loss) from operations 4,144 (304) 13,042 (3,929)

Interest inc
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
2. Genoptix, Inc. Announces Pricing for Initial Public Offering
3. MIB Life Index Reports North American Life Insurance Activity Up 1.4% in December
4. NxStage Medical Reports Fourth Quarter and Full Year 2007 Results
5. Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results
6. Mesa Labs Reports Higher Quarterly Sales and Earnings
7. Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
8. Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results; Teleconference and Webcast to be held on February 11, 2008
9. LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results
10. Neurobiological Technologies Reports Second Quarter Financial Results
11. Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...an cloning could effectively create a replica of a...ate the first cloned human before the end of the y...ian colleague Dr. Severino Antinori has triggered ... cloning banned in an international treaty.// The ...
... the first time, there is reason to believe that a...work. The treatment -- which triggers growth of ne... the arteries -- may provide a viable new option f...ocedures that open blocked arteries and improve bl...
...tudy aimed at settling a long-standing question am...ell as Warfarin, in helping most patients avoid re...rin was more effective but that aspirin was safer....are involved in the final stages of the most commo...
... or human immunodeficiency virus is a retrovirus t...e system T cells. When HIV attacks a cell, the vir... into the nucleus where it inserts itself as part ...ency Syndrome is a collection of 26 clinical condi...
... later a fertilised egg implants in a woman's uter...new research has found.The report in the latest Ne...cise information the timing of implantation - the ...x to 12 days after ovulation, the researchers from...
...hing young children into learning too much too soo...than high achievers, say nursery experts. This set...lead to symptoms of anxiety, such as tantrums and ...rt to their schooling and may revert to bed-wettin...
Other Medicine News:Health News:More about HIV 2Health News:More about HIV 3
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Springer Series editor John Smol receives two prestigious biology awards 8696 1Springer Series editor John Smol receives two prestigious biology awards 8696 2Ethanol production could jeopardize soil productivity 8694 1Ethanol production could jeopardize soil productivity 8694 2Aluminum oxide nanopore beats other materials for DNA analysis 8692 1Aluminum oxide nanopore beats other materials for DNA analysis 8692 2
...developed over Guidants 20-year history, the VOYAG...ion for successful treatment outcomes. It combines...r profile shaft,more flexible markers, and short t...and tortuous anatomy with even greater confidence,...
...developed over Guidants 20-year history, the VOYAG...ion for successful treatment outcomes. It combines...r profile shaft,more flexible markers, and short t...and tortuous anatomy with even greater confidence,...
Tumor Marker AFP
AFP (NTD) Immulite 2500
Medicine Products: